(Q45353001)

13 December 2017

title

Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation (English)

1 reference

13 December 2017

Manuela G Neuman

1

1 reference

13 December 2017

Kristi K McKinney

2

1 reference

13 December 2017

Radu M Nanau

3

1 reference

13 December 2017

Vincent Kong

4

1 reference

13 December 2017

Izabella Malkiewicz

5

1 reference

13 December 2017

Tony Mazulli

6

1 reference

13 December 2017

George Moussa

7

1 reference

13 December 2017

Lawrence B Cohen

8

1 reference

13 December 2017

publication date

16 January 2013

1 reference

13 December 2017

published in

Translational Research

1 reference

13 December 2017

volume

161

1 reference

13 December 2017

issue

5

1 reference

13 December 2017

page(s)

430-440

1 reference

The spectrum of hepatotoxicity.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Drug metabolism, danger signals, and drug-induced hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Epidemiology and risk factors for drug allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Antiepileptic drug-induced hypersensitivity syndrome reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Apoptosis in ibuprofen-induced Stevens-Johnson syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Predicting possible zonisamide hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Ibuprofen-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

The DRESS syndrome: a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Drug-induced and toxic granulomatous hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Phenytoin hypersensitivity: 38 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Fatal liver failure following generalized tonic-clonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Reduction of Plasma Alanine Aminotransferase During Vigabatrin Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

New aspects of drug-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

A practitioner's guide to human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Hypogammaglobulinemia as an early sign of drug-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Safety of celecoxib in individuals allergic to sulfonamide: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Clinical pharmacokinetics of doxycycline and minocycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Evidence for metabolic inertness of doxycycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Analysis and quantitation of a metabolite of doxycycline in mice, rats, and humans by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Doxycycline pharmacokinetics in the absence of renal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Drug-induced photosensitivity: culprit drugs, management and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Phototoxic eruptions due to doxycycline--a dose-related phenomenon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Photoallergic erythroderma due to doxycycline therapy of erythema chronicum migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Update on rosacea and anti-inflammatory-dose doxycycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Acute generalized exanthematous pustulosis due to doxycycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Doxycycline-induced fixed drug eruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Genital fixed drug eruption: cross-reactivity between doxycycline and minocycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Severe drug hypersensitivity reaction in a young woman treated with doxycycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Clinical pattern of cutaneous drug eruption among children and adolescents in north India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Clinical study of cutaneous drug eruptions in 200 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

A case report of doxycycline-induced Stevens-Johnson syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

[Human herpesvirus 6 encephalitis in trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

To kill or to cure: options in host defense against viral infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Noncytolytic control of viral infections by the innate and adaptive immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

A target on the move: innate and adaptive immune escape strategies of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Modulation of cytokine and cytokine receptor/antagonist by treatment with doxycycline and tetracycline in patients with dengue fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Serum Levels of the Th1 Promoter IL-12 and the Th2 Chemokine TARC Are Elevated in Erythema Multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Correlate with Soluble Fas Ligand Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Interleukin-17 in various ocular surface inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

The influence of hepatic damage on serum soluble Fas ligand levels of patients with drug rashes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Prurigo pigmentosa: a clinicopathological study and analysis of associated factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Doxycycline up-regulates the expression of IL-6 and GM-CSF via MAPK/ERK and NF-κB pathways in mouse thymic epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reactions in a patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Clomipramine-induced hypersensitivity syndrome with unusual clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Human CD4+ T cell response to human herpesvirus 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Human herpesvirus 6 infection in adult living related liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

High incidence of active cytomegalovirus infection among septic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

Valproate-induced hepatic injury: analyses of 23 fatal cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2012.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2012.12.012

1 reference

13 December 2017

1 reference